The Management of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With Biologics

被引：14

作者：

Wautlet, A. ^{[1
]}

Bachert, C. ^{[2
,3
,4
]}

Desrosiers, M. ^{[5
]}

Hellings, Peter W. ^{[6
,7
]}

Peters, Anju T. ^{[1
,8
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Allergy Immunol, Chicago, IL 60610 USA

[2] Univ Hosp Munster, Dept Otorhinolaryngol Head & Neck Surg, Munster, Germany

[3] Sun Yat Sen Univ, Affiliated Hosp 1, Int Airway Res Ctr, Dept Otorhinolaryngol, Guangzhou, Peoples R China

[4] Univ Ghent, Fac Med, Dept Otorhinolaryngol, Upper Airways Res Lab, Ghent, Belgium

[5] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada

[6] Univ Hosp Leuven, Dept Otorhinolaryngol, Leuven, Belgium

[7] Univ Ghent, Fac Med, Upper Airways Res Lab, Ghent, Belgium

[8] Northwestern Univ, Feinberg Sch Med, Div Allergy & Immunol, Chicago, IL 60610 USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2023年 / 11卷 / 09期

关键词：

Chronic rhinosinusitis; Nasal polyps; Biologics; RISK-FACTORS; PREVALENCE; OMALIZUMAB; ASTHMA; INFLAMMATION; GENETICS; EFFICACY; SAFETY; STATE;

D O I：

10.1016/j.jaip.2023.04.054

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Chronic rhinosinusitis with nasal polyps affects a significant portion of the worldwide population. This illness is associated with several chronic conditions and has an important impact on patient quality of life, leading to a great societal economic burden. In recent years, biologic medications have been developed and found to be effective in the treatment of chronic rhinosinusitis with nasal polyps. This review focuses on these treatment options and their ability to improve patient outcomes, including quality of life. It also reviews available evidence with regards to patient selection, monitoring of patients after treatment initiation, and comparison of different biologics and with other treatment options such as sinus surgery. & COPY; 2023 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology (J Allergy Clin Immunol Pract 2023;11:2642-51)

引用

页码：2642 / 2651

页数：10

共 61 条

[1] Prevalence and Risk Factors of Chronic Rhinosinusitus, Allergic Rhinitis, and Nasal Septal Deviation Results of the Korean National Health and Nutrition Survey
Ahn, Jae-Cheul
Kim, Jeong-Whun
Lee, Chul Hee
Rhee, Chae-Seo
[J]. JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2016, 142 (02) : 162 - 167
[2] Total and specific IgE in nasal polyps is related to local eosinophilic inflammation
Bachert, C
Gevaert, P
Holtappels, G
Johansson, SGO
van Cauwenberge, P
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (04) : 607 - 614
[3] Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count
Bachert, Claus
Sousa, Ana R.
Han, Joseph K.
Schlosser, Rodney J.
Sowerby, Leigh J.
Hopkins, Claire
Maspero, Jorge F.
Smith, Steven G.
Kante, Oliver
Karidi-Andrioti, Despina E.
Mayer, Bhabita
Chan, Robert H.
Yancey, Steve W.
Chaker, Adam M.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (05) : 1711 - +
[4] Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial
Bachert, Claus
Han, Joseph K.
Desrosiers, Martin Y.
Gevaert, Philippe
Heffler, Enrico
Hopkins, Claire
Tversky, Jody R.
Barker, Peter
Cohen, David
Emson, Claire
Martin, Ubaldo J.
Shih, Vivian H.
Necander, Sofia
Kreindler, James L.
Jison, Maria
Werkstrom, Viktoria
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (04) : 1309 - +
[5] EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management
Bachert, Claus
Han, Joe K.
Wagenmann, Martin
Hosemann, Werner
Lee, Stella E.
Backer, Vibeke
Mullol, Joaquim
Gevaert, Philippe
Klimek, Ludger
Prokopakis, Emanuel
Knill, Andrew
Cavaliere, Carlo
Hopkins, Claire
Hellings, Peter
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (01) : 29 - 36
[6] Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
Bachert, Claus
Han, Joseph K.
Desrosiers, Martin
Hellings, Peter W.
Amin, Nikhil
Lee, Stella E.
Mullol, Joaquim
Greos, Leon S.
Bosso, John V.
Laidlaw, Tanya M.
Cervin, Anders U.
Maspero, Jorge F.
Hopkins, Claire
Olze, Heidi
Canonica, G. Walter
Paggiaro, Pierluigi
Cho, Seong H.
Fokkens, Wytske J.
Fujieda, Shigeharu
Zhang, Mei
Lu, Xin
Fan, Chunpeng
Draikiwicz, Steven
Kamat, Siddhesh A.
Khan, Asif
Pirozzi, Gianluca
Patel, Naimish
Graham, Neil M. H.
Ruddy, Marcella
Staudinger, Heribert
Weinreich, David
Stahl, Neil
Yancopoulos, George D.
Mannent, Leda P.
[J]. LANCET, 2019, 394 (10209) : 1638 - 1650
[7] Clinical Characteristics of Patients with Chronic Rhinosinusitis without Nasal Polyps in an Academic Setting
Benjamin, Mariel R.
Stevens, Whitney W.
Li, Newton
Bose, Sumit
Grammer, Leslie C.
Kern, Robert C.
Tan, Bruce K.
Conley, David B.
Smith, Stephanie S.
Welch, Kevin C.
Schleimer, Robert P.
Peters, Anju T.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (03) : 1010 - 1016
[8] Smoking: An Independent Risk Factor for Lost Productivity in Chronic Rhinosinusitis
Campbell, Adam P.
Hoehle, Lloyd P.
Phillips, Katie M.
Caradonna, David S.
Gray, Stacey T.
Sedaghat, Ahmad R.
[J]. LARYNGOSCOPE, 2017, 127 (08) : 1742 - 1745
[9] Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology
de Loos, Dirk Dietz
Lourijsen, Evelijn S.
Wildeman, Maarten A. M.
Freling, Nicole J. M.
Wolvers, Marije D. J.
Reitsma, Sietze
Fokkens, Wytske J.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (03) : 1207 - 1214
[10] Pilan RRD, 2012, RHINOLOGY, V50, P129, DOI [10.4193/Rhin11.256, 10.4193/Rhino11.256]

← 1 2 3 4 5 6 7 →